SCHEMBL71560

SCHEMBL71560

CCC(=O)N(CCC(=O)O)Cc1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.48
HDAC1 Q13547 4/20 0.45
HDAC6 Q9UBN7 4/20 0.45
HDAC3 O15379 1/20 0.45
HDAC2 Q92769 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
REN P00797 1/20 0.44
FFAR1 O14842 2/20 0.43
KMT2A Q03164 2/20 0.43
CNR2 P34972 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
HPGD P15428 1/20 0.43
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.43
OPRM1 P35372 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14089388 0.89 HDAC3 (0.46) HDAC1HDAC6HDAC3HDAC2NCOR2
SCHEMBL13472619 0.87 ALDH1A1 (0.54) RENKMT2AMEN1ALDH1A1OPRM1
SCHEMBL14672758 0.85 TRPM8 (0.53) TRPM8KMT2ACNR2KDM4EMEN1
SCHEMBL14701531 0.84 TRPM8 (0.50) TRPM8KMT2ACNR2KDM4EMEN1
SCHEMBL14174771 0.83 TRPM8 (0.49) TRPM8KMT2ACNR2KDM4EMEN1
SCHEMBL18117060 0.77 KDM4A (0.51) FFAR1KMT2AMEN1ALDH1A1NPSR1
SCHEMBL5725857 0.76 CNR2 (0.51) HDAC1HDAC6HDAC3HDAC2NCOR2
SCHEMBL16351009 0.75 ALDH1A1 (0.50) HDAC1HDAC3HDAC2HPGDALDH1A1
SCHEMBL71846 0.74 HSD17B10 (0.55) HDAC1HDAC6HDAC3HDAC2NCOR2
SCHEMBL23972262 0.72 RAB9A (0.66) FFAR1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536122-B2 Acylated GLP-1 compounds NOVO NORDISK A/S (DK) 2013-09-17 US disclosed
US-20120295847-A1 Acylated GLP-1 Compounds NOVO NORDISK A/S (DK) 2012-11-22 US disclosed
US-8129343-B2 Acylated GLP-1 compounds NOVO NORDISK A/S (DK) 2012-03-06 US disclosed
US-20090156478-A1 Acylated GLP-1 Compounds NOVO NORDISK A/S (DK) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156478-A1 Acylated GLP-1 Compounds GLP1R, GIPR, GCGR TRPM8 2798/4885HDAC1 393/4885HDAC6 227/4885
US-20120295847-A1 Acylated GLP-1 Compounds GLP1R, GIPR, GCGR TRPM8 2798/4885HDAC1 393/4885HDAC6 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.